Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
22.86
Dollar change
-0.64
Percentage change
-2.72
%
IndexRUT P/E- EPS (ttm)-2.70 Insider Own6.36% Shs Outstand53.11M Perf Week-8.71%
Market Cap1.19B Forward P/E- EPS next Y-0.53 Insider Trans-4.06% Shs Float50.22M Perf Month0.35%
Income-143.56M PEG- EPS next Q-0.21 Inst Own97.26% Short Float6.65% Perf Quarter-23.11%
Sales312.77M P/S3.81 EPS this Y80.23% Inst Trans-1.99% Short Ratio4.06 Perf Half Y61.10%
Book/sh5.15 P/B4.44 EPS next Y24.29% ROA-29.35% Short Interest3.34M Perf Year116.68%
Cash/sh4.62 P/C4.95 EPS next 5Y20.00% ROE-43.02% 52W Range7.42 - 34.84 Perf YTD90.50%
Dividend Est.- P/FCF977.61 EPS past 5Y-21.96% ROI-48.32% 52W High-34.39% Beta1.84
Dividend TTM- Quick Ratio3.87 Sales past 5Y33.42% Gross Margin64.96% 52W Low208.09% ATR (14)1.39
Dividend Ex-Date- Current Ratio4.10 EPS Y/Y TTM-60.58% Oper. Margin-18.45% RSI (14)41.73 Volatility5.82% 5.66%
Employees643 Debt/Eq0.11 Sales Y/Y TTM5.26% Profit Margin-45.90% Recom2.11 Target Price33.71
Option/ShortYes / Yes LT Debt/Eq0.09 EPS Q/Q67.70% Payout- Rel Volume0.95 Prev Close23.50
Sales Surprise3.56% EPS Surprise43.14% Sales Q/Q23.35% EarningsNov 04 AMC Avg Volume822.36K Price22.86
SMA20-4.22% SMA50-7.07% SMA20017.53% Trades Volume779,444 Change-2.72%
Date Action Analyst Rating Change Price Target Change
Aug-28-24Initiated Wells Fargo Underweight $28
Aug-19-24Upgrade BTIG Research Neutral → Buy $40
May-13-24Downgrade Raymond James Outperform → Mkt Perform
May-01-24Upgrade Craig Hallum Hold → Buy $15
Nov-09-23Upgrade Stephens Equal-Weight → Overweight $10
Aug-15-23Upgrade Raymond James Mkt Perform → Outperform $12
May-11-23Downgrade BTIG Research Buy → Neutral
Mar-07-23Downgrade Stephens Overweight → Equal-Weight $19 → $9
Mar-03-23Downgrade Raymond James Strong Buy → Mkt Perform
Mar-03-23Downgrade Craig Hallum Buy → Hold $26 → $9
Dec-11-24 07:00AM
07:00AM
Dec-03-24 09:40AM
Nov-29-24 10:46AM
Nov-25-24 09:55AM
09:35AM Loading…
Nov-15-24 09:35AM
Nov-14-24 09:40AM
Nov-12-24 07:05AM
Nov-07-24 09:04AM
Nov-05-24 01:03PM
02:06AM
Nov-04-24 05:03PM
04:05PM
Oct-23-24 07:00AM
Oct-21-24 07:00AM
03:06PM Loading…
Oct-17-24 03:06PM
Oct-16-24 08:17AM
Oct-15-24 06:00AM
Oct-11-24 04:30PM
Oct-09-24 03:35PM
07:05AM
Oct-08-24 04:05PM
06:05AM
Sep-13-24 08:35PM
08:33PM
Sep-12-24 07:01AM
Aug-26-24 06:06AM
04:36AM
Aug-16-24 02:10PM
Aug-09-24 09:15AM
12:00PM Loading…
Aug-07-24 12:00PM
Aug-06-24 03:58PM
Jul-31-24 08:00PM
06:05PM
05:01PM
04:05PM
Jul-16-24 07:05AM
Jun-03-24 07:05AM
May-30-24 07:05AM
May-29-24 08:05AM
07:05AM
May-16-24 04:05PM
May-14-24 07:17AM
May-13-24 10:12AM
May-10-24 02:26PM
02:21PM
11:46AM
May-09-24 07:00PM
05:32PM
04:05PM
May-07-24 09:15AM
May-03-24 04:10PM
Apr-29-24 04:05PM
Apr-19-24 04:05PM
Apr-18-24 03:47AM
Apr-16-24 04:02PM
Apr-09-24 07:00AM
Apr-01-24 08:40AM
Mar-11-24 04:10PM
Feb-29-24 10:43AM
06:59AM
Feb-28-24 07:00PM
05:28PM
04:57PM
04:05PM
Feb-27-24 04:05PM
Feb-26-24 09:15AM
Feb-21-24 04:05PM
07:00AM
Jan-26-24 09:45PM
Jan-11-24 04:05PM
Jan-09-24 07:00AM
Dec-19-23 07:00AM
Dec-08-23 09:55AM
Nov-22-23 09:55AM
Nov-10-23 10:15AM
Nov-08-23 05:02PM
04:05PM
Nov-06-23 07:38AM
Nov-02-23 04:05PM
Nov-01-23 04:02PM
Oct-17-23 07:00AM
Oct-03-23 07:12PM
06:00PM
04:43PM
Oct-02-23 11:06AM
Sep-19-23 07:00AM
Sep-14-23 02:00AM
Aug-31-23 07:00AM
Aug-17-23 07:00AM
Aug-15-23 09:59AM
Aug-11-23 07:00AM
Aug-09-23 09:30AM
Aug-08-23 06:05PM
05:02PM
04:05PM
Aug-07-23 11:08AM
Aug-03-23 07:00AM
Aug-02-23 07:00AM
Jul-25-23 07:00AM
CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Novack Jeffrey AdamSecretary and General CounselDec 04 '24Sale26.001,91749,842110,237Dec 06 04:32 PM
Jeffrey Adam NovackOfficerDec 04 '24Proposed Sale24.961,91747,848Dec 04 04:42 PM
Maag PeterDirectorNov 26 '24Option Exercise12.245,00061,200335,024Dec 03 08:54 PM
Maag PeterDirectorNov 26 '24Sale25.005,000125,000330,024Dec 03 08:54 PM
Novack Jeffrey AdamSecretary and General CounselNov 18 '24Sale21.775,534120,477113,377Dec 03 04:31 PM
Novack Jeffrey AdamSecretary and General CounselNov 25 '24Sale24.001,22329,352112,154Dec 03 04:31 PM
PETER MAAGDirectorNov 26 '24Proposed Sale24.115,000120,550Nov 26 04:25 PM
JEFFREY NOVACKOfficerNov 25 '24Proposed Sale23.131,22328,288Nov 25 04:45 PM
JEFFREY NOVACKOfficerNov 18 '24Proposed Sale21.175,534117,155Nov 18 05:11 PM
Bickerstaff GeorgeDirectorNov 01 '24Option Exercise5.747,48142,962123,027Nov 05 04:42 PM
Johnson Alexander LSee RemarksAug 20 '24Option Exercise23.4839,466926,662324,449Aug 22 05:15 PM
Johnson Alexander LSee RemarksAug 21 '24Option Exercise23.4821,557506,158306,540Aug 22 05:15 PM
Johnson Alexander LSee RemarksAug 20 '24Sale33.1739,4661,309,087284,983Aug 22 05:15 PM
Johnson Alexander LSee RemarksAug 21 '24Sale32.5821,557702,327284,983Aug 22 05:15 PM
Maag PeterDirectorAug 20 '24Option Exercise7.9626,708212,596365,576Aug 22 04:43 PM
Maag PeterDirectorAug 20 '24Sale33.0435,5521,174,493330,024Aug 22 04:43 PM
Johnson Alexander LSee RemarksAug 19 '24Sale33.5534,2311,148,335284,983Aug 21 04:38 PM
Johnson Alexander LOfficerAug 20 '24Proposed Sale33.0061,0232,013,759Aug 20 06:25 PM
Johnson Alexander LOfficerAug 19 '24Proposed Sale33.5534,2311,148,355Aug 20 06:21 PM
Maag PeterDirectorAug 20 '24Proposed Sale33.5135,5521,191,478Aug 20 05:13 PM
Bickerstaff GeorgeDirectorMay 14 '24Option Exercise10.005,25552,550104,976May 16 04:38 PM
Maag PeterDirectorApr 29 '24Option Exercise5.2713,28169,991327,264May 01 04:38 PM